American International Group’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

American International Group’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-408	Closed	-$33K	–	3302
2022 Q1	$33K	Sell	408 -29	-7%	-$3.58K	﹤0.01%	2961
2021 Q4	$89K	Buy	437 +80	+22%	+$20K	﹤0.01%	2767
2021 Q3	$115K	Buy	357 +225	+170%	+$65.6K	﹤0.01%	2744
2021 Q2	$34	Buy	+132	New	+$40.2K	﹤0.01%	3040

Other funds holding VINC

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

American International Group's VINC Position: Q2 2022 in Review

American International Group sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2022, closing a stake of 408 shares — an estimated $33K sold.

American International Group first reported a position in VINC in Q2 2021 and held it in 4 quarters. The position peaked at $115K in Q3 2021. 51 funds tracked by Wall St. Rank hold VINC as of Q2 2022.

American International Group reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
American International Group sold 408 Vincerx Pharma, Inc. Common Stock shares in Q2 2022, an estimated $33K.
American International Group first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
American International Group's Vincerx Pharma, Inc. Common Stock position peaked at $115K in Q3 2021.
51 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.